Hologic (HOLX) Tops Q3 EPS by 37c, Revenues Beat; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Hologic Announces Financial Results for Third Quarter of Fiscal 2020
July 29, 2020 4:01 PM EDTRevenue of $822.9 Million Declines 3.5% due to Cynosure Divestiture, 3.1% in Constant Currency
Organic Revenue Increases 7.7%, 8.1% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses
Company Posts GAAP Diluted EPS of $0.53, Non-GAAP Diluted EPS of $0.75
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal third quarter ended June 27, 2020.
Our strong third quarter financial results reflect the incredible contributions the Hologic team is making in the fight against the... More
